Irwin Scher is listed as a director on 17 SEC Form D filings by 1 issuer between Dec 2009 and Aug 2017: INTARCIA THERAPEUTICS, INC (Boston, MA — biotechnology — 2009–2017; $524.6M reported sold to 90 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Glen Sato (17 shared filings), Thomas Alessi (16 shared filings), Bryan Roberts (14 shared filings), Kurt Graves (14 shared filings), David J. Franklin (12 shared filings) and 22 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Irwin. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 17 public filings for Irwin Scher and found 9 differences, 1 worth asking the sponsor about: Paid seller listed without a CRD number: Raptor International, LLC; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.